Replimune Group, Inc. (REPL)
5.22
+0.29
(+5.88%)
USD |
NASDAQ |
May 15, 16:00
5.18
-0.04
(-0.77%)
After-Hours: 20:00
Replimune Group Market Cap : 431.03M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 295.71M |
| Catalyst Pharmaceuticals, Inc. | 3.816B |
| Spyre Therapeutics, Inc. | 6.506B |
| Bristol Myers Squibb Co. | 116.40B |
| ANI Pharmaceuticals, Inc. | 1.774B |
Market Cap Related Metrics
| PEG Ratio | -0.1044 |
| Price to Book Value | 2.047 |
| Price | 5.22 |
| Earnings Yield | -68.63% |
| PEGY Ratio | -0.1044 |